Molecular Express, Inc.
Molecular Express is a research and development technology company specializing in the application of life science technologies to address market needs across a broad spectrum of industries. The Company’s lipid and “Molecular Guided Particle System” (Molecular GPS™) delivery platform is the basis for many active programs targeting anti-cancer therapeutics, drug delivery systems, vaccines, and nanoparticulate drug delivery technologies
Molecular Express is applying the Molecular GPS™ technology platform to develop vaccines for influenza, herpes, HIV, Anthrax and A. fumigatus. In addition, studies demonstrate that the Molecular GPS™ technology platform can be used to develop a variety of therapeutics to combat cancers and emerging infectious diseases.
Molecular Express conducts contract formulation, analytical, and clinical trial supply for complex delivery systems.